Cargando…

Strategic Modification of Gut Microbiota through Oral Bacteriotherapy Influences Hypoxia Inducible Factor-1α: Therapeutic Implication in Alzheimer’s Disease

Dysbiosis contributes to Alzheimer’s disease (AD) pathogenesis, and oral bacteriotherapy represents a promising preventative and therapeutic opportunity to remodel gut microbiota and to delay AD onset and progression by reducing neuroinflammation and amyloid and tau proteins aggregation. Specificall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonfili, Laura, Gong, Chunmei, Lombardi, Francesca, Cifone, Maria Grazia, Eleuteri, Anna Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745493/ https://www.ncbi.nlm.nih.gov/pubmed/35008786 http://dx.doi.org/10.3390/ijms23010357

Ejemplares similares

Gut Microbiome and Mycobiome Alterations in an In Vivo Model of Alzheimer’s Disease
por: D’Argenio, Valeria, et al.
Publicado: (2022)

Bacterial Lysate from the Multi-Strain Probiotic SLAB51 Triggers Adaptative Responses to Hypoxia in Human Caco-2 Intestinal Epithelial Cells under Normoxic Conditions and Attenuates LPS-Induced Inflammatory Response
por: Lombardi, Francesca, et al.
Publicado: (2023)

Bacteriotherapy
Publicado: (1887)

Oxygen Sparing Effect of Bacteriotherapy in COVID-19
por: Ceccarelli, Giancarlo, et al.
Publicado: (2021)

Bacteriotherapy in Breast Cancer
por: Yaghoubi, Atieh, et al.
Publicado: (2019)

Microbiota modulation counteracts Alzheimer’s disease progression influencing neuronal proteolysis and gut hormones plasma levels
por: Bonfili, Laura, et al.
Publicado: (2017)

Bacteriotherapy for inflammatory bowel disease
por: Yoshimatsu, Yusuke, et al.
Publicado: (2021)

Understanding the Gut–Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders
por: Zheng, Yadong, et al.
Publicado: (2023)

Immortalized Alzheimer’s Disease Astrocytes: Characterization of Their Proteolytic Systems
por: Gong, Chunmei, et al.
Publicado: (2023)

Modulation of Gut Microbiota and Neuroprotective Effect of a Yeast-Enriched Beer
por: Cecarini, Valentina, et al.
Publicado: (2022)

Influence of Microbiota on NSAID Enteropathy: A Systematic Review of Current Knowledge and the Role of Probiotics
por: Rekatsina, Martina, et al.
Publicado: (2020)

Lung-Directed Bacteriotherapy in Cystic Fibrosis: Could It Be an Option?
por: Batoni, Giovanna, et al.
Publicado: (2022)

Gut microbiota and its complex role. The experience of the National Institute for Infectious Diseases “Prof. Dr. Matei Balş” in fecal bacteriotherapy for Clostridium difficile infection
por: Apostolescu, Cătălin, et al.
Publicado: (2013)

Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection()
por: Adamu, Blessing O, et al.
Publicado: (2013)

Emerging applications of cancer bacteriotherapy towards treatment of pancreatic cancer
por: Henderson, Emily A., et al.
Publicado: (2023)

Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice
por: Lawley, Trevor D., et al.
Publicado: (2012)

The Epithelial Barrier Model Shows That the Properties of VSL#3 Depend from Where it is Manufactured
por: Palumbo, Paola, et al.
Publicado: (2019)

Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study
por: Ceccarelli, Giancarlo, et al.
Publicado: (2021)

Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients
por: Santinelli, Letizia, et al.
Publicado: (2022)

Controlling skin microbiome as a new bacteriotherapy for inflammatory skin diseases
por: Ito, Yoshihiro, et al.
Publicado: (2022)

Managing the Skin Microbiome as a New Bacteriotherapy for Inflammatory Atopic Dermatitis
por: Dewi, Dian Andriani Ratna, et al.
Publicado: (2023)

The Efficacy of Faecal Microbiota Transplant and Rectal Bacteriotherapy in Patients with Recurrent Clostridioides difficile Infection: A Retrospective Cohort Study
por: Svensson, Camilla Kara, et al.
Publicado: (2022)

Oral bacteriotherapy in children with recurrent respiratory infections: a real-life study
por: Tarantino, Vincenzo, et al.
Publicado: (2020)

Mucoadhesive probiotic backpacks with ROS nanoscavengers enhance the bacteriotherapy for inflammatory bowel diseases
por: Liu, Jun, et al.
Publicado: (2022)

Flavan‐3‐ol Microbial Metabolites Modulate Proteolysis in Neuronal Cells Reducing Amyloid‐beta (1‐42) Levels
por: Cecarini, Valentina, et al.
Publicado: (2021)

The Effects of Low-Nickel Diet Combined with Oral Administration of Selected Probiotics on Patients with Systemic Nickel Allergy Syndrome (SNAS) and Gut Dysbiosis
por: Lombardi, Francesca, et al.
Publicado: (2020)

Targeting Proteolysis with Cyanogenic Glycoside Amygdalin Induces Apoptosis in Breast Cancer Cells
por: Cecarini, Valentina, et al.
Publicado: (2022)

Fr576 ORAL BACTERIOTHERAPY IN PATIENTS WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: Marazzato, Massimiliano, et al.
Publicado: (2021)

Gut Microbiota and Immunotherapy for Alzheimer’s Disease
por: Dai, Chun-Ling, et al.
Publicado: (2022)

Secretome of Adipose Tissue-Derived Stem Cells (ASCs) as a Novel Trend in Chronic Non-Healing Wounds: An Overview of Experimental In Vitro and In Vivo Studies and Methodological Variables
por: Lombardi, Francesca, et al.
Publicado: (2019)

Methods of Isolation, Characterization and Expansion of Human Adipose-Derived Stem Cells (ASCs): An Overview
por: Palumbo, Paola, et al.
Publicado: (2018)

Hypoxia: The “Invisible Pusher” of Gut Microbiota
por: Han, Ni, et al.
Publicado: (2021)

Structure/activity virtual screening and in vitro testing of small molecule inhibitors of 8-hydroxy-5-deazaflavin:NADPH oxidoreductase from gut methanogenic bacteria
por: Cuccioloni, Massimiliano, et al.
Publicado: (2020)

Gut microbiota modification suppresses the development of pulmonary arterial hypertension in an SU5416/hypoxia rat model
por: Sanada, Takayuki J., et al.
Publicado: (2020)

Fecal Bacteriotherapy: A Case Report in an Immunosuppressed Patient with Ulcerative Colitis and Recurrent Clostridium difficile Infection
por: Zainah, Hadeel, et al.
Publicado: (2012)

Soluble Fraction from Lysates of Selected Probiotic Strains Differently Influences Re-Epithelialization of HaCaT Scratched Monolayer Through a Mechanism Involving Nitric Oxide Synthase 2
por: Lombardi, Francesca, et al.
Publicado: (2019)

PPARα-Selective Antagonist GW6471 Inhibits Cell Growth in Breast Cancer Stem Cells Inducing Energy Imbalance and Metabolic Stress
por: Castelli, Vanessa, et al.
Publicado: (2021)

Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines
por: Lombardi, Francesca, et al.
Publicado: (2022)

Production Conditions Affect the In Vitro Anti-Tumoral Effects of a High Concentration Multi-Strain Probiotic Preparation
por: Cinque, Benedetta, et al.
Publicado: (2016)

Soluble Fraction from Lysate of a High Concentration Multi-Strain Probiotic Formulation Inhibits TGF-β1-Induced Intestinal Fibrosis on CCD-18Co Cells
por: Lombardi, Francesca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g8v1inhu8lbv7v2cd30knthhue